According to retrospective studies the conservative management of periappendicular abscess is associated with decreased complication and re-operation rate compared with open appendectomy. Large abscesses require percutaneous drainage. Sometimes percutaneous drainage is not possible because of anatomical position of the abscess and surgical treatment is needed. The purpose of this study is evaluate whether laparoscopic appendectomy is suitable for the first-line treatment in patients with periappendicular abscess. The hypothesis of the study is that laparoscopic management of periappendicular abscess is suitable for the first-line treatment and it does not increase time of hospitalization or complication rate compared with conservative management.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
60
Laparoscopic appendectomy and laparoscopic drainage of the abscess. If appendectomy is not possible due to technical difficulties only laparoscopic drainage is performed. Patients are treated with the same antimicrobial therapy as the control group (intravenous Cefuroxime 1,5 g x 3 per day plus Metronidazole 500 mg x 3 per day).
Patients are treated with intravenous Cefuroxime 1,5 g x 3 per day plus Metronidazole 500 mg x 3 per day. If the abscess is at least 3 cm in diameter percutaneous ultrasound guided drainage is performed.
Helsinki University Central Hospital, Meilahti Hospital
Helsinki, Finland
Time of hospitalization within the first 60 days after randomization
Time frame: Day 60 after randomization
Need of additional interventions
Interventions include percutaneous drainage and operations
Time frame: Within the first 60 days after randomization
Residual abscess
Time frame: On day 7 after randomization
Attempted procedure not successfully performed
In the laparoscopy group appendectomy was not possible. In the conservative group planned percutaneous drainage was not possible.
Time frame: During the first 24 hours after randomization
The number of complications
Any complication occurring within 60 days from randomization. Both medical and surgical complications are included.
Time frame: Within 60 days from randomization
Number recurrent abscesses
Time frame: Within 60 days after randomization
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.